TerminatedEUCTR 2004-000686-35
Official study titleA 52-week open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2000 mg/d in the treatment of manic episodes of bipolar I disorder
Original registry wording; source language not specified.
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FinlandBipolarityHistorical research record
- Countries
- Finland
- Sponsor
- Novartis Pharma AG
CompletedEUCTR 2004-001981-41
Official study titleBipolar Affective disorder: Lithium/ANti-Convulsant Evaluation
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalyBipolarityHistorical research record
- Countries
- Italy
- Sponsor
- UNIVERSITY OF OXFORD (University)
CompletedEUCTR 2021-000862-14
Official study titleEffects of low dose Aspirin in bipolar disorder – a randomized controlled trial (the A-Bipolar RCT)
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In DenmarkBipolarityHistorical research record
- Countries
- Denmark
- Sponsor
- Copenhagen Affective Disorder research Center (CADIC),
CompletedEUCTR 2005-001233-16
Official study titleEfficacy of Aripiprazole in Combination with Lithium or Valproate in the Long Term Treatment of Mania in Patients with Bipolar I Disorder Partially Nonresponsive to Lithium or Valproate Monotherapy...
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicBipolarityHistorical research record
- Countries
- Czechia
- Sponsor
- Bristol-Myers Squibb International Corporation
CompletedEUCTR 2004-000202-49
Official study titleEfficacy of Aripiprazole in Combination with Valproate or Lithium in the Treatment of Mania in Patients with Bipolar I Disorder Partially Nonresponsive to Valproate or Lithium Monotherapy Revised...
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In EstoniaBipolarityHistorical research record
- Countries
- Estonia, Hungary, Italy, + 1 other
- Sponsor
- Bristol-Myers Squibb International Corporation
CompletedEUCTR 2005-005072-32
Official study titleIs it possible to modify the course of manic relapse? A pilot study of the effectiveness of quetiapine in preventing the development of manic episodes in Bipolar Disorder.
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In United KingdomBipolarityHistorical research record
- Countries
- United Kingdom
- Sponsor
- Kings College London (IOP) / South London and Maudsley NHS Trust (Co-sponsorship)
CompletedEUCTR 2004-001482-17
Official study titleOlanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolar I disorder.
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In LithuaniaBipolarityHistorical research record
- Countries
- Lithuania
- Sponsor
- Eli Lilly and Company
Not recruitingISRCTN75279027
This study isn't currently recruiting.
In United KingdomBipolarityResearch study
- Countries
- United Kingdom
- Sponsor
- Lancaster University (UK)
CompletedNCT00312494
Official study titleA Three-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Add-On Oral Ziprasidone in Subjects With Acute Mania Treated With Lithium or Divalproex
This study has finished and is no longer accepting participants.
Multiple locations, including DothanBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
CompletedNCT00159783
Official study titleA Double-Blind, 40-Week Continuation Study Evaluating the Safety of Asenapine and Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501007 (Secondary Title: ARES)
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT00143182
Official study titleA Double-Blind, 9-Week Extension Study Evaluating the Safety and Maintenance of Effect of Asenapine vs. Olanzapine in the Treatment of Subjects With Acute Mania Clinical Trial Protocol A7501006 (Secondary Title: ARES)
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18+
- Countries
- Sponsor
- Organon and Co
CompletedNCT00986128
Official study titleA Comparative Study of the Steady State Pharmacokinetics of Lithium Before and During Multiple Oral Daily Topiramate (RWJ-17021) Dosing in Patients With Bipolar Disorders
This study has finished and is no longer accepting participants.
Location not clearly listedBipolarityMedication studyAges 18–60
- Countries
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
